---
title: "CQP: In the third quarter, the net profit attributable to the parent company was 102 million yuan, an increase of 87.94% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262914226.md"
description: "On October 27th, CQP announced that in the third quarter of 2025, it achieved operating revenue of 21.023 billion yuan, a year-on-year increase of 5.57%; the net profit attributable to shareholders of the listed company was 102 million yuan, a year-on-year increase of 87.94%; basic earnings per share were 0.06 yuan. In the first three quarters, it achieved operating revenue of 62.211 billion yuan, a year-on-year increase of 4.22%; the net profit attributable to shareholders of the listed company was 384 million yuan, a year-on-year increase of 31.41%"
datetime: "2025-10-27T13:24:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262914226.md)
  - [en](https://longbridge.com/en/news/262914226.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262914226.md)
---

# CQP: In the third quarter, the net profit attributable to the parent company was 102 million yuan, an increase of 87.94% year-on-year

On October 27th, CQP announced that it achieved an operating income of 21.023 billion yuan in the third quarter of 2025, a year-on-year increase of 5.57%; the net profit attributable to shareholders of the listed company was 102 million yuan, a year-on-year increase of 87.94%; basic earnings per share were 0.06 yuan. In the first three quarters, it achieved an operating income of 62.211 billion yuan, a year-on-year increase of 4.22%; the net profit attributable to shareholders of the listed company was 384 million yuan, a year-on-year increase of 31.41%

### Related Stocks

- [000950.CN](https://longbridge.com/en/quote/000950.CN.md)

## Related News & Research

- [Shanghai Henlius says China regulator clears HLX48 Phase 1 trial IND for solid tumors](https://longbridge.com/en/news/287189347.md)
- [Orion Pharma to reveal initial results from Phase 1/2 TEADES study of ODM-212 at 2026 ASCO® Meeting.](https://longbridge.com/en/news/287177935.md)
- [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md)
- [US working with small biotech firm on experimental Ebola treatment, Bloomberg News reports](https://longbridge.com/en/news/287108072.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)